BHCM
ABBV icon

Boulder Hill Capital Management’s AbbVie ABBV Stock Holding History

Boulder Hill Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,400
Closed -$456K – 124
2022
Q3 		$456K Buy
+3,400
New +$488K 0.35% 59

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boulder Hill Capital Management's ABBV Position: Q4 2022 in Review

Boulder Hill Capital Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 3,400 shares — an estimated $456K sold.

Boulder Hill Capital Management first reported a position in ABBV in Q3 2022 and held it in 1 quarter. The position peaked at $456K in Q3 2022. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Boulder Hill Capital Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 3,400 AbbVie shares in Q4 2022, an estimated $456K.
  • Boulder Hill Capital Management first reported a position in AbbVie in Q3 2022 and held it in 1 quarter.
  • Boulder Hill Capital Management's AbbVie position peaked at $456K in Q3 2022.
  • 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Boulder Hill Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.